Our Team

Success depends on the right combination of expertise and experience. Our project teams are hand-picked to meet your needs.

Lucy Owen

Guiding clients through the complex and dynamic Rx-to-OTC switch regulatory process

Saul Shiffman, PhD

Senior Scientific Advisor, Behavioral Science, Study Design, and Analysis

Directing support for Rx-to-OTC switch, with emphasis on behavioral data and communication

George Quesnelle

Senior Strategic Advisor, OTC Commercialization and Optimization

Marshalling onset-to-completion resources for Rx-to-OTC switch success

Christine Sweeney, PhD, MPH

Director, Issues Management

Establishing the data driven benefit-risk case to support regulatory approval of consumer healthcare products

Lisa Zapawa, MD, MPH

Director, Medical Science

Providing scientific and strategic support for Rx-to-OTC switch efforts

Karen Sees, DO

Senior Scientific Advisor, Drug Development and Pharmacovigilance

Speak to an expert.